ARKK vs GOSS
ARK Innovation ETF (ARKK) versus Gossamer Bio Inc (GOSS) — a side-by-side from cached financials, not a winner call.
ARK Innovation ETF (ARKK) common stock listed on US.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
ARKK does not have a complete income-statement cache yet.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
ARKK currently screens at market cap $0. GOSS currently screens at market cap $47.0M.
Not investment advice. Open the ARKK and GOSS stock pages for the full models.
Not investment advice.